These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 18064648

  • 1. SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients.
    Swanson KD, Winter JM, Reis M, Bentires-Alj M, Greulich H, Grewal R, Hruban RH, Yeo CJ, Yassin Y, Iartchouk O, Montgomery K, Whitman SP, Caligiuri MA, Loh ML, Gilliland DG, Look AT, Kucherlapati R, Kern SE, Meyerson M, Neel BG.
    Genes Chromosomes Cancer; 2008 Mar; 47(3):253-9. PubMed ID: 18064648
    [Abstract] [Full Text] [Related]

  • 2. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG.
    Cancer Res; 2004 Dec 15; 64(24):8816-20. PubMed ID: 15604238
    [Abstract] [Full Text] [Related]

  • 3. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
    Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG, Kucherlapati RS.
    Nat Genet; 2007 Jan 15; 39(1):70-4. PubMed ID: 17143285
    [Abstract] [Full Text] [Related]

  • 4. Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma.
    Jongmans MC, Hoogerbrugge PM, Hilkens L, Flucke U, van der Burgt I, Noordam K, Ruiterkamp-Versteeg M, Yntema HG, Nillesen WM, Ligtenberg MJ, van Kessel AG, Kuiper RP, Hoogerbrugge N.
    Genes Chromosomes Cancer; 2010 Jul 15; 49(7):635-41. PubMed ID: 20461756
    [Abstract] [Full Text] [Related]

  • 5. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I.
    Fabretto A, Kutsche K, Harmsen MB, Demarini S, Gasparini P, Fertz MC, Zenker M.
    Eur J Med Genet; 2010 Jul 15; 53(5):322-4. PubMed ID: 20673819
    [Abstract] [Full Text] [Related]

  • 6. Investigation of gene dosage imbalances in patients with Noonan syndrome using multiplex ligation-dependent probe amplification analysis.
    Nyström AM, Ekvall S, Thuresson AC, Denayer E, Legius E, Kamali-Moghaddam M, Westermark B, Annerén G, Bondeson ML.
    Eur J Med Genet; 2010 Jul 15; 53(3):117-21. PubMed ID: 20302979
    [Abstract] [Full Text] [Related]

  • 7. Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations.
    Denayer E, Devriendt K, de Ravel T, Van Buggenhout G, Smeets E, Francois I, Sznajer Y, Craen M, Leventopoulos G, Mutesa L, Vandecasseye W, Massa G, Kayserili H, Sciot R, Fryns JP, Legius E.
    Genes Chromosomes Cancer; 2010 Mar 15; 49(3):242-52. PubMed ID: 19953625
    [Abstract] [Full Text] [Related]

  • 8. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors.
    Mutesa L, Pierquin G, Janin N, Segers K, Thomée C, Provenzi M, Bours V.
    Cancer Genet Cytogenet; 2008 Apr 01; 182(1):40-2. PubMed ID: 18328949
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies.
    Komatsuzaki S, Aoki Y, Niihori T, Okamoto N, Hennekam RC, Hopman S, Ohashi H, Mizuno S, Watanabe Y, Kamasaki H, Kondo I, Moriyama N, Kurosawa K, Kawame H, Okuyama R, Imaizumi M, Rikiishi T, Tsuchiya S, Kure S, Matsubara Y.
    J Hum Genet; 2010 Dec 01; 55(12):801-9. PubMed ID: 20882035
    [Abstract] [Full Text] [Related]

  • 18. Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype?
    Brasil AS, Malaquias AC, Wanderley LT, Kim CA, Krieger JE, Jorge AA, Pereira AC, Bertola DR.
    Arq Bras Endocrinol Metabol; 2010 Nov 01; 54(8):717-22. PubMed ID: 21340158
    [Abstract] [Full Text] [Related]

  • 19. [New findings in Noonan syndrome and Leopard syndrome: activating mutations in RAF-1 and SOS-1].
    Dereure O.
    Ann Dermatol Venereol; 2008 Nov 01; 135(8-9):624-5. PubMed ID: 18789305
    [No Abstract] [Full Text] [Related]

  • 20. Malignant diseases in Noonan syndrome and related disorders.
    Hasle H.
    Horm Res; 2009 Dec 01; 72 Suppl 2():8-14. PubMed ID: 20029231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.